MODD Modular Medical, Inc.
USHealthcareAs of 2026-07-10 16:00
Why MODD matters now
Modular Medical, Inc. (MODD) is a US stock in Healthcare. The latest InvestLog snapshot shows $3.99 with -1.72% on the session and $8.4M in market capitalization; recent performance reads 1-month +54.65% and YTD -52.84%.
The latest financial table shown here is Q3 2026, with revenue of $0.00, net income of $-7.4M, and EPS of $-3.30. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -240.5%.
The latest indexable market news headline is "Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements" from Accesswire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $—; recent insider activity includes Schmid Kevin filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
1.92
P/S
0.00
EV/EBITDA
-0.33
DCF Value
$9.75
FCF Yield
-240.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-245.8%
ROA
-261.0%
ROIC
-314.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $0.00 | $-7.4M | $-3.30 |
| Q2 2026 | $0.00 | $-7.8M | $-4.20 |
| Q1 2026 | $0.00 | $-6.7M | $-3.60 |
| Q4 2025 | $0.00 | $-4.9M | $-3.60 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.06
Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.